Clinical Trial Update: Levetiracetam XR in Very Heavy Drinkers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of extended-release levetiracetam for very heavy drinkers with alcoholism has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Levetiracetam XR (levetiracetam)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2012-07-06